We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
7301 Background: Surgery with complete resection of disease remains the optimal treatment for non-small cell lung cancer. We initiated a Phase II study to determine if patients with marginally(More)
  • 1